If we are able to fill the the trial, prove efficiency within 6 months, clear Australian approval process in short order, Get manufacturers lined up and approved. Distribution late 2017? Time to book a trip to Australia. That would be a great Christmas present this year.
A2-73 is clearly here a candidate. I am convinced that the efficacy is good for return to scores of MMSE 28-30. Call it cure or control. I await the 15 month data fro confirmation of the picture revealed in the 57 week data.
News 
Market Data 
Discover 
